Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EVANTHEA TRIAL: A Pragmatic, Randomized, Controlled Trial to Evaluate the Effectiveness of a Precision Medicine Treatment Approach for Early Dementia and Mild Cognitive Impairment

NCT05894954 is registered in ClinicalTrials.gov with Alzheimer's Prevention and Reversal Project, Inc. as lead sponsor.

NCT NCT05894954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05894954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EVANTHEA TRIAL: A Pragmatic, Randomized, Controlled Trial to Evaluate the Effectiveness of a Precision Medicine Treatment Approach for Early Dementia and Mild Cognitive Impairment
Lead sponsor
Alzheimer's Prevention and Reversal Project, Inc.
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2023
Completion date
February 9, 2026
Enrollment
73 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

dementia, mild, mild cognitive impairment